Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis.

Sara PizzamiglioChiara Maura CiniselliTiziana Triulzi Chiara GargiuliLoris De CeccoEvandro de Azambuja Debora Fumagalli Christos Sotiriou Nadia HarbeckMiguel IzquierdoPaolo G NuciforoJens HuoberVera CappellettiSaverio CinieriMartine PiccartMaria Grazia DaidoneGiancarlo PruneriMario Paolo Colombo Elda TagliabuePaolo VerderioSerena Di Cosimo

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

Immuno-phenotyping holds the promise to complement current predictive models in HER2-positive breast cancer and to assist in new therapeutic development.

Keyphrases

positive breast cancer
rectal cancer
lymph node
high throughput
locally advanced
big data
single molecule
mesenchymal stem cells
machine learning
bone marrow
cell therapy